Is There a Decreased Risk of Intracerebral Hemorrhage and Mortality in Obese Patients Treated with Intravenous Thrombolysis in Acute Ischemic Stroke?

Background: The current guidelines do not recommend increasing the dose of intravenous recombinant tissue plasminogen activator (IV rt-PA) for ischemic stroke patients weighing >100 kg. Obese patients are therefore receiving an IV rt-PA dose

Source: Journal of Stroke and Cerebrovascular Diseases - March 4, 2013 Category: Neurology Authors: Ameer E. Hassan, Saqib A. Chaudhry, Vishal Jani, Mikayel Grigoryan, Asif A. Khan, Malik M. Adil, Adnan I. Qureshi Tags: Original Articles Source Type: research